Dr. Reddy's Laboratories
152 hedge funds and large institutions have $796M invested in Dr. Reddy's Laboratories in 2019 Q3 according to their latest regulatory filings, with 18 funds opening new positions, 51 increasing their positions, 53 reducing their positions, and 16 closing their positions.
1,691% more call options, than puts
Call options by funds: $394K | Put options by funds: $22K
13% more first-time investments, than exits
New positions opened: 18 | Existing positions closed: 16
1% more funds holding
Funds holding: 150 → 152 (+2)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
2% less capital invested
Capital invested by funds: $812M → $796M (-$16.1M)
4% less repeat investments, than reductions
Existing positions increased: 51 | Existing positions reduced: 53
2.03% less ownership
Funds ownership: 65.23% → 63.2% (-2%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Mitsubishi UFJ Trust & Banking
Tokyo,
Japan
|
+$15.9M |
| 2 |
Goldman Sachs
New York
|
+$10.9M |
| 3 |
Renaissance Technologies
New York
|
+$10.4M |
| 4 |
Marshall Wace
London,
United Kingdom
|
+$5.42M |
| 5 |
MWNA
Marshall Wace North America
New York
|
+$5.32M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$9.2M |
| 2 |
Swiss National Bank
Zurich,
Switzerland
|
-$5.31M |
| 3 |
Acadian Asset Management
Boston,
Massachusetts
|
-$4.79M |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$4.63M |
| 5 |
Grantham, Mayo, Van Otterloo & Co (GMO)
Boston,
Massachusetts
|
-$3.96M |
RDY Hedge Fund Activity: Q3 2019 in Review
152 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Dr. Reddy's Laboratories (RDY) for Q3 2019, worth a combined $796M — down 2% from $812M a quarter earlier.
Buyers outnumbered sellers: 18 funds opened new RDY positions and 16 closed out — a net gain of 2 holders — while 51 added to existing stakes and 53 trimmed.
The largest buyer was Mitsubishi UFJ Trust & Banking, adding an estimated $15.9M. The largest seller was BlackRock, cutting an estimated $9.2M.
- 152 institutional investors held Dr. Reddy's Laboratories (RDY) as of Q3 2019, up from 150 in Q2 2019.
- Funds reported $796M of Dr. Reddy's Laboratories stock for Q3 2019, down 2% quarter-over-quarter.
- 18 funds opened new Dr. Reddy's Laboratories positions in Q3 2019 and 16 closed out, a net change of +2 holders.
- The largest Dr. Reddy's Laboratories buyer in Q3 2019 was Mitsubishi UFJ Trust & Banking, an estimated $15.9M added.
- The largest Dr. Reddy's Laboratories seller in Q3 2019 was BlackRock, an estimated $9.2M sold.
Based on aggregated 13F filings for Q3 2019.